ESR1 and breast carcinoma: Histopathological tumor analysis identifies 15–20% of breast cancers cases as triple-negative breast cancer (TNBC), characterized by lack of expression of estrogen receptor, progesterone receptor, and low expression of human epidermal growth factor receptor (HER2) [1].